QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.

Sarepta Therapeutics provided $15m in a series A round for the startup, which is working on genetic medicines for rare diseases.

The retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises that will go toward further developing its drug pipeline.

Nine companies will participate in the internet company’s three-month accelerator programme, which is set to launch next month.

The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.

Insurer MACSF has taken part in round for patient data tool provider Savana, which will use the cash to expand to the US market.

Providence Health and Services has exited the healthcare satisfaction analyser in a purchase of undisclosed size by Press Ganey.

The diagnostics technology developer picked up Jemincare and Haier Biomedical for its second funding round since spinning off from parent company 3D Medicines in 2018.

Softbank China and Sinopharm-CICC Capital returned for a series B-plus round after backing the online pharmacy's 2019 series B.

The immuno-oncology therapy developer filed to raise up to $50m, two years after securing money from investors including Biomed Realty and Alexandria Real Estate Equities.